KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,165,010 | +21.7% | 3,118,308 | -1.3% | 0.00% | +100.0% |
| Q2 2023 | $44,498,769 | +22.1% | 3,160,424 | -6.7% | 0.00% | 0.0% |
| Q1 2023 | $36,435,081 | -32.1% | 3,386,160 | -5.5% | 0.00% | -50.0% |
| Q4 2022 | $53,653,551 | +15.2% | 3,581,679 | -1.3% | 0.00% | 0.0% |
| Q3 2022 | $46,589,000 | +36.0% | 3,628,460 | +2.6% | 0.00% | +100.0% |
| Q2 2022 | $34,259,000 | -1.4% | 3,535,357 | +1.2% | 0.00% | 0.0% |
| Q1 2022 | $34,734,000 | -15.3% | 3,494,325 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $41,007,000 | +15.4% | 3,483,852 | +11.7% | 0.00% | 0.0% |
| Q3 2021 | $35,540,000 | +2.1% | 3,120,322 | +24.8% | 0.00% | 0.0% |
| Q2 2021 | $34,815,000 | -16.4% | 2,499,290 | +11.0% | 0.00% | 0.0% |
| Q1 2021 | $41,657,000 | +7.7% | 2,250,611 | +2.8% | 0.00% | 0.0% |
| Q4 2020 | $38,684,000 | +38.0% | 2,189,230 | +19.7% | 0.00% | 0.0% |
| Q3 2020 | $28,028,000 | -8.1% | 1,829,519 | +52.9% | 0.00% | 0.0% |
| Q2 2020 | $30,495,000 | +111.1% | 1,196,820 | +28.3% | 0.00% | 0.0% |
| Q1 2020 | $14,443,000 | +37.7% | 933,013 | -1.6% | 0.00% | – |
| Q4 2019 | $10,490,000 | +10.3% | 948,457 | -15.2% | 0.00% | – |
| Q3 2019 | $9,513,000 | -36.5% | 1,117,919 | +1.0% | 0.00% | -100.0% |
| Q2 2019 | $14,990,000 | -14.3% | 1,107,091 | +14.4% | 0.00% | 0.0% |
| Q1 2019 | $17,482,000 | -3.5% | 968,019 | +50.1% | 0.00% | 0.0% |
| Q4 2018 | $18,120,000 | +57.7% | 645,111 | +43.2% | 0.00% | – |
| Q3 2018 | $11,489,000 | +6541.0% | 450,573 | +4405.7% | 0.00% | – |
| Q2 2018 | $173,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |